Hypothesis: Telomere length in enterochromaffin (EC) cells operates as a read‑out of the informational entropy of serotonergic signaling networks, such that progressive shortening reflects increasing noise in gut‑brain communication and drives age‑related decline. EC cells synthesize >90% of peripheral serotonin via TPH1, and serotonin release modulates intestinal motility, immune tone, and vagal afferent activity. Telomere position effect (TPE) can silence nearby genes when heterochromatin spreads from shortened telomeres, a mechanism documented in fibroblasts and stem cells【https://blog.cellsignal.com/cell-process-what-role-do-the-telomeres-play-in-senescence】. We propose that in EC cells, telomere shortening induces TPE‑mediated repression of the TPH1 locus and of genes governing vesicle exocytosis (e.g., SNAP25, VAMP2), thereby lowering serotonin output and increasing stochastic variation in release. This loss of deterministic signaling raises the informational entropy of the serotonergic signal, which the telomere length itself mirrors as a biophysical clock counting molecular disorder rather than replication cycles.

Predictions:

1. We don't yet know whether EC telomeres shorten with age, but we can test it: EC cells isolated from aged mice will show significantly shorter telomeres than those from young mice, coinciding with reduced TPH1 mRNA, lower basal serotonin release, and heightened cell‑to‑cell variability in release measured by single‑cell amperometry.
2. Forced expression of telomerase (TERT) in aged EC cultures will rescue telomere length, restore TPH1 expression, normalize serotonin release variance, and decrease senescence markers (p16, p21) without altering proliferation rates.
3. Pharmacological increase of serotonergic noise (e.g., low‑dose TPH1 inhibitor) in young EC cells will accelerate telomere shortening over successive passages, linking entropy generation to attrition.
4. In vivo, feeding mice a phenylacetic acid–rich diet (known to induce endothelial senescence via telomere dysfunction) will exacerbate EC telomere loss and serotonin dysregulation, mirroring microbiome‑associated aging phenotypes.

These predictions are falsifiable: if telomere length does not correlate with TPH1 expression or serotonin variability, or if telomerase activation fails to rescue serotonin signaling despite telomere elongation, the hypothesis is refuted. Conversely, confirmation would support a model where telomeres serve as a molecular gauge of informational entropy in specialized neuroendocrine cells, linking chromosomal biology to aging of the gut‑brain axis.

References:

• Telomere position effect and senescence: https://blog.cellsignal.com/cell-process-what-role-do-the-telomeres-play-in-senescence
• Telomere dysfunction‑induced foci and senescence pathways: https://pmc.ncbi.nlm.nih.gov/articles/PMC10410008/
• Oxidative stress and telomere shortening in metabolic disease: https://www.intechopen.com/chapters/51979
• Microbiome metabolites inducing telomere‑dependent senescence: https://pmc.ncbi.nlm.nih.gov/articles/PMC5839326/
• Single‑cell serotonin release measurement: https://doi.org/10.1101/2023.11.17.567594